Your browser doesn't support javascript.
loading
Bevacizumab may improve quality of life, but not overall survival in glioblastoma: an epidemiological study.
Gramatzki, D; Roth, P; Rushing, E J; Weller, J; Andratschke, N; Hofer, S; Korol, D; Regli, L; Pangalu, A; Pless, M; Oberle, J; Bernays, R; Moch, H; Rohrmann, S; Weller, M.
Afiliación
  • Gramatzki D; Department of Neurology, University Hospital Zurich, Zurich, Switzerland. Electronic address: dorothee.gramatzki@usz.ch.
  • Roth P; Department of Neurology, University Hospital Zurich, Zurich, Switzerland.
  • Rushing EJ; Department of Neuropathology, University Hospital Zurich, Zurich, Switzerland.
  • Weller J; Department of Neurology, University Hospital Zurich, Zurich, Switzerland.
  • Andratschke N; Department of Radiation Oncology, University Hospital Zurich, Zurich, Switzerland.
  • Hofer S; Department of Oncology, University Hospital Zurich, Zurich, Switzerland.
  • Korol D; Department of Cancer Registry of the Cantons Zurich and Zug, University Hospital Zurich, Zurich, Switzerland.
  • Regli L; Department of Neurosurgery, University Hospital Zurich, Zurich, Switzerland.
  • Pangalu A; Department of Neuroradiology, University Hospital Zurich, Zurich, Switzerland.
  • Pless M; Department of Oncology, Kantonsspital Winterthur, Winterthur, Switzerland.
  • Oberle J; Department of Neurosurgery, Kantonsspital Winterthur, Winterthur, Switzerland.
  • Bernays R; Department of Neurochirurgie Hirslanden, Zurich, Switzerland.
  • Moch H; Department of Pathology and Molecular Pathology, University Hospital Zurich, Zurich, Switzerland.
  • Rohrmann S; Department of Cancer Registry of the Cantons Zurich and Zug, University Hospital Zurich, Zurich, Switzerland.
  • Weller M; Department of Neurology, University Hospital Zurich, Zurich, Switzerland.
Ann Oncol ; 29(6): 1431-1436, 2018 06 01.
Article en En | MEDLINE | ID: mdl-29617713
Asunto(s)
Texto completo
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Bases de datos: MEDLINE Asunto principal: Calidad de Vida / Neoplasias Encefálicas / Glioblastoma / Bevacizumab / Antineoplásicos Inmunológicos Tipo de estudio: Observational_studies / Prognostic_studies / Risk_factors_studies Límite: Aged / Female / Humans / Male Idioma: En Revista: Ann Oncol Asunto de la revista: NEOPLASIAS Año: 2018 Tipo del documento: Article
Texto completo
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Bases de datos: MEDLINE Asunto principal: Calidad de Vida / Neoplasias Encefálicas / Glioblastoma / Bevacizumab / Antineoplásicos Inmunológicos Tipo de estudio: Observational_studies / Prognostic_studies / Risk_factors_studies Límite: Aged / Female / Humans / Male Idioma: En Revista: Ann Oncol Asunto de la revista: NEOPLASIAS Año: 2018 Tipo del documento: Article